Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients

View ORCID ProfileDinesh Mohanraj, Samuel Baldwin, Satbeer Singh, Alun Gordon, View ORCID ProfileAlison Whitelegg
doi: https://doi.org/10.1101/2021.12.03.21267250
Dinesh Mohanraj
1Faculty of Medicine, Biology and Health, The University of Manchester, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dinesh Mohanraj
  • For correspondence: dinesh.mohanraj@postgrad.manchester.ac.uk
Samuel Baldwin
2Department of Blood Sciences, Portsmouth Hospital University NHS Trust, Portsmouth, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satbeer Singh
2Department of Blood Sciences, Portsmouth Hospital University NHS Trust, Portsmouth, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alun Gordon
2Department of Blood Sciences, Portsmouth Hospital University NHS Trust, Portsmouth, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison Whitelegg
3Department of Clinical Immunology, University Hospital Southampton NHS Trust, Southampton, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alison Whitelegg
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objective SARS-CoV-2 vaccinations have demonstrated vaccine immunogenicity in healthy volunteers, however, efficacy in immunosuppressed patients is less well characterised. Subsequently, there is an urgent need to address the impact of immunosuppression on vaccine immunogenicity.

Methods Serological, T-cell ELISpot, cytokines and immunophenotyping investigations were used to assess vaccine responses (either BNT162b2 mRNA or ChAdOx1 nCoV-19) in double-vaccinated patients receiving immunosuppression for renal transplants or haematological malignancies (n=13). Immunological responses in immunosuppressed patients (VACC-IS) were compared to immunocompetent vaccinated (VACC-IC, n=12), unvaccinated (UNVACC, n=11) and infection-naïve unvaccinated (HC, n=3) cohorts. All participants, except HC, had prior COVID-19 infection.

Results T-cell responses were identical between VACC-IS and VACC-IC (92%) to spike-peptide (S) stimulation. UNVACC had the highest T-cell non-responders (n=3), whereas VACC-IC and VACC-IS both had one T-cell non-responder. No significant differences in humoral responses were observed between VACC-IC and VACC-IS, with 92% (12/13) of VACC-IS patients demonstrating seropositivity. One VACC-IS failed to seroconvert, however had detectable T-cell responses. All VACC-IC participants were seropositive for anti-spike antibodies. Furthermore, both VACC-IS and VACC-IC participants elicited strong Th1 cytokine response with immunodominance towards S-peptide. Differences in T-cell immunophenotyping were seen between VACC-IS and VACC-IC, with lower CD8+ activation and T-effector memory phenotype observed in VACC-IS.

Conclusion SARS-CoV-2 vaccines are immunogenic in patients receiving immunosuppressive therapy, with responses comparable to vaccinated immunocompetent participants. Lower humoral responses were seen in patients treated with B-cell depleting therapeutics, but with preserved T-cell responses. We suggest further work to correlate both protective immunity and longevity of these responses in both healthy and immunosuppressed patients.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Oxford Immunotec and Beckman Coulter provided the study with free of cost evaluation kits.

Both Oxford Immunotec and Beckman Coulter had no other direct involvement in this study. This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study received ethical approval from Health Research Authority national ethics committee (London-City and East research ethics committee, IRAS: 291009)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data available upon request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted December 05, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
Dinesh Mohanraj, Samuel Baldwin, Satbeer Singh, Alun Gordon, Alison Whitelegg
medRxiv 2021.12.03.21267250; doi: https://doi.org/10.1101/2021.12.03.21267250
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
Dinesh Mohanraj, Samuel Baldwin, Satbeer Singh, Alun Gordon, Alison Whitelegg
medRxiv 2021.12.03.21267250; doi: https://doi.org/10.1101/2021.12.03.21267250

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Allergy and Immunology
Subject Areas
All Articles
  • Addiction Medicine (238)
  • Allergy and Immunology (520)
  • Anesthesia (124)
  • Cardiovascular Medicine (1414)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (582)
  • Epidemiology (10273)
  • Forensic Medicine (6)
  • Gastroenterology (526)
  • Genetic and Genomic Medicine (2618)
  • Geriatric Medicine (254)
  • Health Economics (496)
  • Health Informatics (1728)
  • Health Policy (788)
  • Health Systems and Quality Improvement (671)
  • Hematology (266)
  • HIV/AIDS (564)
  • Infectious Diseases (except HIV/AIDS) (12074)
  • Intensive Care and Critical Care Medicine (647)
  • Medical Education (272)
  • Medical Ethics (83)
  • Nephrology (287)
  • Neurology (2450)
  • Nursing (144)
  • Nutrition (376)
  • Obstetrics and Gynecology (487)
  • Occupational and Environmental Health (566)
  • Oncology (1317)
  • Ophthalmology (398)
  • Orthopedics (145)
  • Otolaryngology (235)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (342)
  • Pediatrics (776)
  • Pharmacology and Therapeutics (328)
  • Primary Care Research (295)
  • Psychiatry and Clinical Psychology (2392)
  • Public and Global Health (4991)
  • Radiology and Imaging (892)
  • Rehabilitation Medicine and Physical Therapy (522)
  • Respiratory Medicine (681)
  • Rheumatology (309)
  • Sexual and Reproductive Health (254)
  • Sports Medicine (244)
  • Surgery (296)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)